Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis

British Journal of Rheumatology

Volumn 36, Issue 4, 1997, Pages 433-439

  Cutolo, M ^a,d   Giusti, M ^b   Villaggio, B ^a   Barone, A ^a   Accardo, S ^a   Sulli, A ^a   Granata, O ^c   Carruba, G ^c   Castagnetta, L ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Division of Rheumatology   (Italy)

Author keywords

Androgens; Cyclosporin A; Hypertrichosis; Macrophages; Rheumatoid arthritis; Synoviocytes; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ANDROSTERONE; CYCLOSPORIN A; EPIANDROSTERONE; TESTOSTERONE;

ADULT; AGED; ANDROGEN METABOLISM; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTRICHOSIS; MACROPHAGE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE METABOLISM;

EID: 0030844676     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.4.433     Document Type: Article

References (63)

1. Borel JF, Gunn H. Cyclosporine as a new approach to therapy. Ann NY Acad Sci 1986;475:307-19.
2. Picascia DD, Gardern JM, Frenkel RK, Roenigk HH Jr. Treatment of resistant severe psoriasis with systemic cyclosporine. J Am Acad Dermatol 1987;17:408-14.
3. Feutren G. The optimal use of cyclosporin A in autoimmune diseases. J Autoimmun 1992;5(suppl. A): 183-95.
4. Shevac EM. The effects of cyclosporin A on the immune system. Annu Rev Immunol 1985;3:397-423.
5. Graffenried von B, Krupp P. Side effects of cyclosporine (Sandimmun) in renal transplant recipient patients and in patients with autoimmune diseases. Transplant Proc 1986;18:876-83.
6. Schmidt JB, Gebhart W, Kopsa H, Spona J. Does cyclosporin A influence sex hormone levels? Exp Clin Endocrinol 1986;88:207-11.
7. Lindholm A, Pousette A, Carlström K, Klintmalam R. Cyclosporin-associated hypertrichosis is not related to sex hormone levels following renal transplantation. Nephron 1988;50:199-204.
8. Krueger BA, Trakshel GM, Sluss PM, Maines MD. Cyclosporin-mediated depression of luteinizing hormone receptors and heme biosynthesis in rat testes: a possible mechanism for decrease in serum testosterone. Endocrinology 1991;129:2647-54.
9. Vexiau P, Fiet J, Boudou P, Villette J et al. Increase in plasma 5a-androstane-3α, 17β-diol glucuronide as a marker of peripheral androgen action in hypertrichosis: a side-effect induced by cyclosporine A. J Steroid Biochem 1990;35:133-7.
10. Cutolo M, Sulli A, Giusti M, Barone A, Seriolo B, Accardo S. Increase in 5α-androstane-3α, 17β-diol glucuronide as a possible marker of the androgen-mediated immunosuppressive activity exerted by Cyclosporine A: preliminary results. Clin Exp Rheumatol 1994;12:350-1.
11. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts influence on the production of interleukin-4 (IL-4), IL-5, and γ-interferon (γ-IFN), but not IL-2 activated murine T cells. Blood 1991;78:688-99.
12. Cutolo M, Accardo S, Villaggio B et al. Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum 1992;35:1007-15.
13. Cutolo M, Villaggio B, Accardo S et al. Cultured macrophage-like synoviocytes from rheumatoid arthritis synovium metabolize testosterone and exhibit inhibition of IL-1 production. Arthritis Rheum 1993; 36:S158.
14. Kirschner MA, Samojlik E, Szmal E. Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopatic hypertrichosis. J Clin Endocrinol Metab 1987;65:597-601.
15. Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJA. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992;133:467-75.
16. Cooper MH, Gregory SH, Thomson AW, Fung JJ, Cohen Z, Lavy GA. Evaluation of the influence of FK 506, Rapamycin and Cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug 'carry-over' effect. Transplant Proc 1991;23:2957-8.
17. Dupuy P, Bagot M, Michel L, Descourt B, Dubertret L. Cyclosporin A inhibits the antigen-presenting function of freshly isolated Langerhans cells in vitro. J Invest Dermatol 1991;96:408-13.
18. Gilfar A, Etzioni A, Pillar T, Assy B, Eidelman S. Effect of cyclosporine A on the regulation of Ia antigen keratinocytes expression. Clin Immunol Immunopathol 1991;60:349-55.
19. Palay DA, Cluff CW, Wentworth PA, Ziegler HK. Cyclosporine inhibits macrophage-mediated antigen presentation. J Immunol 1986;136:4348-53.
20. Arnett F, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
21. An International Consensus report: the use of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 1993;32(suppl. 1):1-3.
22. Mihatsch MJ, WolfF K. Report of a meeting: consensus conference on cyclosporin A for psoriasis, February 1992. Br J Dermatol 1992;126:621-3.
23. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-7.
24. Fredericksson T, Petterson U. Severe psoriasis oral therapy with a new retinoid. Dermatologica 1978;157: 238-44.
25. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5.
26. Lindblad S, Wredmark T. Traumatic synovitis analysed by arthroscopy and immunohistopathology. Br J Rheumatol 1990;29:422-5.
27. Kay A, Wingrave SJ. Oral contraceptives and rheumatoid arthritis. Lancet 1983;i:1437.
28. Tsoukas CD, Provvedini DM, Manolangas SC. 1,25 hydroxy vitamin D3: a novel immunoregulatory hormone. Science 1984;224:1438-40.
29. Ettinger B, Genan HK, Cann CE. Long-term estrogen replacement prevents bone loss and fractures. Ann Intern Med 1985;102:319-24.
30. Castagnetta L, Granata OM, Lo Casto M, Calabrò M, Arcuri F, Carruba G. Simple approach to measure metabolic pathways of steroids in living cells. J Chromatogr 1991;572:25-39.
31. Leake RE, Habib F. Steroid hormone receptors: assay and characterization. In: Green R, Leake RE, eds. Steroid hormones: a practical approach. Oxford: IRL Press, 1987.
32. Van Rijthoven AWAM, Dijkmans BAC, The HSG, Boers M, Cats R. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: A randomized, double-blind, multicentre study. J Rheumatol 1991;18: 815-20.
33. Tugwell P, Bombardier C, Gent M et al. Low dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990;335:1051-5.
34. Pasero GP, Priolo F, Marubini E et al. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996;39:1006-15.
35. Vermeulen A, Giagulli VA. Physiopathology of plasma androstanediol-glucuronide. J Steroid Biochem Mol Biol 1991;39:829-33.
36. Morimoto I, Edmiston A, Hawks D, Horton R. Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men. J Clin Endocrinol Metab 1981;52:772-8.
37. Masi AT, Feigenbaum SL, Chatteron RT. Hormonal and pregnancy relationship to rheumatoid arthritis: convergent effects with immunologic and microvascular system. Semin Arthritis Rheum 1995;25:1-27.
38. Hall GM, Perry LA, Spector TP. Depressed levels of DHEAS in postmenopausal women with rheumatoid arthritis but no relation to axial bone density. Ann Rheum Dis 1993;52:211-4.
39. Klein H, Bressel M, Kastendieck H, Voigt KD. Biochemical endocrinology of prostate cancer. In: Voigt KD, Knabbe C, eds. Endocrine dependent tumors. New York: Raven Press, 1991:131-63.
40. Castagnetta L, Granata OM, Polito L, Blasi L, Cannella S, Carruba G. Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells. J Steroid Biochem Mol Biol 1994;49:351-7.
41. Masi AT, Feigenbaum SL, Chatteron RT, Cutolo M. Integrated Hormonal-Immunological-Vascular ('H-I-V' Triad) system interactions in rheumatic diseases. Clin Exp Rheumatol 1995;13:203-16.
42. Masi AT, da Silva JAP, Cutolo M. Perturbations of the hypothalamic pituitary gonadal axis in rheumatoid arthritis. In: Chikanza IC, ed. Neuroendocrine immune mechanisms of rheumatic diseases. Baillière's Clin Rheumatol 1996;10:295-331.
43. Paulson RJ, Serafini PC, Catalino JA, Lobo RA. Measurements of 3α-17β-androstanediol glucuronide in serum and urine and the correlation with skin 5α-reductase activity. Fertil Steril 1986;46:222-6.
44. Wing EJ, Magee DM, Whiteside TL, Kaplan SS, Shadduck RK. Recombinant human granulocyte-macrophage colony-stimulating factor enhances monocyte toxicity and secretion of tumor necrosis factor α and interferon in cancer patients. Blood 1989;73:643-6.
45. Fischer HG, Frosch S, Reske K, Reske-Kunz AB. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J Immunol 1988;141:3882-8.
46. Espevic T, Figari IS, Shalaby MR et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor-beta. J Exp Med 1987;166:571-6.
47. Russel RGG, Graveley R, Coxon F et al. Cyclosporin A. Mode of action and effects on bone and joint tissues. Scand J Rheumatol 1992;21(suppl. 95):9-18.
48. Cutolo M, Accardo S, Villaggio B et al. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996;81:820-7.
49. Manca F, Fenoglio D, Kunkl A, Caltabellotta M, Celada F. Effect of cyclosporine on the antigen-presenting function of human and murine accessory cells. Transplantation 1989;46:40s-43s.
50. Benson A, Ziegler HK. Macrophages as targets for inhibition by cyclosporine. Transplantation 1989;47:696-703.
51. Roberts MS, Knight SC. Low-dose immunosuppression by cyclosporine operating via antigen-presenting dendritic cells. Transplantation 1990;50:91-5.
52. Teunisen MBM, Jager MHDE, Kapsenburg ML, Bos JD. Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells. Br J Dermatol 1991;125:309-16.
53. Roth J, Goebler M, Erpenstein U, Sorg C. Differential regulation of the macrophage-specific surface antigen RM3/1 by cyclosporine, azathioprine and dexamethasone. Transplantation 1994;57:127-33.
54. Matsushima Y, Baba T. The in vivo effect of cyclosporine A on macrophages. J Exp Pathol 1990;5:39-48.
55. Kahn D, Gavaler JS, Lai H et al. Effect of cyclosporine on hepatic cytosolic estrogen and androgen receptor levels before and after partial hepatectomy. Dig Dis Sci 1990;35:6-11.
56. Hirasawa K, Enosawa S. Sex-associated differences in organ transplantation: different effects of steroid hormones, testosterone, oestradiol, progesterone and prednisolone on the survival time of allogenic skin graft in rats treated with cyclosporin A. Transplant Proc 1991;23:714-5.
57. Hirasawa K, Enosawa S. Effects of sex steroid hormones on sex-associated differences in the survival time of allogenic skin graft in rats. Evidence that testosterone enhances and oestradiol reverses the immunosuppressive activity of cyclosporine. Transplantation 1990;50:637-41.
58. Førre Ø, Bjerkhoel F, Salvesen CF. An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis. Arthritis Rheum 1987;30:88-92.
59. Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: A double-blind, placebo controlled study in 52 patients. Ann Rheum Dis 1988; 47:127-33.
60. Førre Ø, Norwegian Arthritis Study Group. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Arthritis Rheum 1994;57:1506-12.
61. Kahan BD. Cyclosporine. N Engl J Med 1989;32:1725-34.
62. Tokuda M, Kurata N, Mizoguchi A et al. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum 1994;37:551-8.
63. Cutolo M, Castagnetta L. Immunomodulatory mechanisms mediated by sex hormones in rheumatoid arthritis. Ann NY Acad Sci 1996;784:534-41.